• Päivi Paldánius

Dr. Paldánius is Worldwide Brand Medical Director Diabetes at Novartis. She is the medical lead of the ongoing landmark study, VERIFY, and has led the design, implementation and publication of diverse clinical programmes such as the INTERVAL study exploring the individualised targets in elderly persons with T2DM and the Time2DoMore in diabetes programme addressing the barriers to optimised diabetes care and perceptions and the reasons behind clinical inertia. 

In parallel with her pharmaceutical career, Päivi is a member of an academic research group at the Children’s Hospital, Helsinki University Central Hospital, where her research interests focus on regulation of bone metabolism and glucose homeostasis. 

Iniciar sesión/Registrarse Ampliar Reducir